Effects of Exercise on Myeloid-Derived Suppressor Cell-Related Tumor Progression and Metastasis by Garritson, Jacob
University of Northern Colorado 
Scholarship & Creative Works @ Digital UNC 
Dissertations Student Research 
8-2020 
Effects of Exercise on Myeloid-Derived Suppressor Cell-Related 
Tumor Progression and Metastasis 
Jacob Garritson 
Follow this and additional works at: https://digscholarship.unco.edu/dissertations 
Recommended Citation 
Garritson, Jacob, "Effects of Exercise on Myeloid-Derived Suppressor Cell-Related Tumor Progression and 
Metastasis" (2020). Dissertations. 707. 
https://digscholarship.unco.edu/dissertations/707 
This Text is brought to you for free and open access by the Student Research at Scholarship & Creative Works @ 
Digital UNC. It has been accepted for inclusion in Dissertations by an authorized administrator of Scholarship & 






























UNIVERSITY OF NORTHERN COLORADO 
Greeley, Colorado 
The Graduate School 
 
 
EFFECTS OF EXERCISE ON MYELOID-DERIVED  
SUPPRESSOR CELL-RELATED TUMOR  





A Dissertation Submitted in Partial Fulfillment  
of the Requirements for the Degree of  















College of Natural and Health Sciences 






This Dissertation by: Jacob Garritson 
Entitled: Effects of Exercise on Myeloid-Derived Suppressor Cell-Related Tumor 
Progression and Metastasis 
 
has been approved as meeting the requirement for the Degree of Doctor of Philosophy in 
College of Natural and Health Sciences in School or Department of Sport and Exercise 
Science, Program of Exercise Physiology 
 
Accepted by the Doctoral Committee 
 
____________________________________________________ 












Nicholas Pullen Ph.D., Faculty Representative 
 
Date of Dissertation Defense: June 10, 2020 
 





Cindy Wesley, Ph.D.  
Interim Associate Provost and Dean  
The Graduate School 









Garritson, Jacob. Effects of Exercise on Myeloid-Derived Suppressor Cell-Related Tumor 
Progression and Metastasis. Published Doctoral Dissertation, University of 
Northern Colorado, 2020. 
 
 
Myeloid-derived suppressor cells (MDSCs) are potent suppressors of immune 
function and may play a key role in the development and progression of metastatic 
cancers. Aerobic exercise has been shown to have anticancer effects, yet the mechanisms 
behind this protection are largely unknown. Purpose: to determine the effects of physical 
activity on MDSC accumulation and function. Methods: Female BALB/c mice were 
assigned to one of two primary groups: sedentary tumor (SED+TUM) or wheel run tumor 
(WR+TUM). After 6 weeks of voluntary wheel running, all animals were randomly 
subdivided into 4 different timepoint groups; 16, 20, 24, and 28 days post-tumor cell 
injection. All mice were inoculated with 4T1 mammary carcinoma cells in the mammary 
fat pad and WR groups continued to run for the specified time post-injection. Spleen, 
blood, and tumor samples were analyzed using flow cytometry to assess proportions of 
MDSCs (CD11b/Ly6G/Ly6C).  MDSCs were purified from the spleen to assess T-cell 
suppressive capacity and metastatic lesions were quantified in the lung. Results  
 Compared to SED+TUM, levels of MDSCs in the spleen were significantly lower (p < 
0.05) in WR+TUM at day 16 (33 ± 5%; 23 ± 10% of total cells, respectively) and day 20 
(34 ± 8%; 24 ± 5% of total cells, respectively). Additionally, there were significantly 




significant (p = 0.08) trend toward lower MDSCs at day 28 in the tumors of WR+TUM. 
While this delay in MDSC accumulation did not translate to a decrease in tumor growth, 
physical activity led to 62% and 26% fewer metastatic lung nodules at days 24 and 28, 
respectively. At day 28, MDSCs harvested from SED+TUM significantly suppressed 
CD3+CD4+ T-cell proliferation (3.2 ± 1.3 proliferation index) while T-cell proliferation in 
WR+TUM MDSC co-cultures (5.1 ± 1.7 proliferation index) was not different from 
controls. Conclusions: These findings suggest that physical activity may delay the 
accumulation of immunosuppressive MDSCs providing a broader window of opportunity 
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Recent reports from the American Cancer Society project that more than 1.7 
million new cancer cases will occur in 2019, and over 600,000 people will die from 
cancer this year. In general, incidence rates for all types of cancer have decreased from 
2009-2015. This is potentially credited to a sharp decline in colorectal cancers (CRC) in 
men over the past 5 years as overall cancer incidence rates in women have remained 
relatively stable for the past few decades (Siegel, Miller, & Jemal, 2019). For example, 
female breast cancer incidence increased by 0.4% from 2004-2015, which has been partly 
attributed to the obesity epidemic (Cronin et al., 2018). Consequently, a significant 
number of people are living with cancer, which is the second leading cause of death in 
the United States (Heron & Anderson, 2016).  
Epidemiological data support an association between physical activity and a 
decrease in cancer risk and mortality. This is important to consider due to the worldwide 
increase in physically inactive individuals. It is estimated that 31% of adults are 
physically inactive worldwide and this number continues to rise each year (Hallal et al., 
2012). Fortunately, regular physical activity (PA) can reduce the risk for developing 
cancer. Specifically, meeting the current recommendation of 150 min/week of moderate-
vigorous PA (MVPA) may result in a 12% reduction in the risk for developing breast 




cancer risk and mortality have been proposed, including a reduction in sex hormones, 
insulin levels, and chronic low grade inflammation (Dethlefsen, Pedersen, & Hojman, 
2017). Additionally, exercise has the potential to influence the balance between pro-
inflammatory and anti-inflammatory signals, as well as the recruitment and function of 
myeloid and lymphoid lineage immune cells. This relationship is of particular interest, 
especially in the context of cancer and cancer therapy. 
Myeloid-derived suppressor cells (MDSCs) have garnered significant interest 
among cancer researchers in recent years. As the name suggests, MDSCs are immune 
cells of myeloid origin with the ability to suppress both innate and adaptive immune 
responses. Also, MDSCs have been implicated as contributors in the development of 
metastatic disease. MDSC induction is a result of overproduction of tumor-produced 
growth factors and pro-inflammatory signals. For example, granulocyte-macrophage 
colony-stimulating factor (GM-CSF) has been shown to generate MDSCs with potent 
immune suppressive function (Morales, Kmieciak, Knutson, Bear, & Manjili, 2010; 
Serafini et al., 2004). Additionally, interleukin-6 (IL-6) and interleukin-1β (IL-1β) are 
two pro-inflammatory cytokines that are important for the accumulation and suppressive 
function of MDSCs (Bunt et al., 2007; Zhang et al., 2018). Chronic inflammation is one 
of the hallmarks of cancer and the resulting generation of immune suppressive MDSCs 
supports the hypothesis that inflammation drives tumor progression and metastasis by 
suppressing antitumor immune responses. MDSCs also play a role in the failure of 
modern immunotherapies. For instance, melanoma patients with low levels of circulating 




Therefore, targeting MDSCs is a logical approach to improve the outcomes of patients 
receiving immunotherapy. 
Exercise has been shown to have antitumor effects and one potential mechanism 
explaining this is a reduction in chronic low-grade inflammation, or perhaps even more 
important, is an acute increase in anti-inflammatory cytokines. IL-6 has been studied 
extensively and has traditionally been thought of as a pro-inflammatory cytokine. 
However, depending on the context, IL-6 may also stimulate anti-inflammatory signals. 
Specifically, increases in muscle-derived IL-6 during exercise leads to an increase in the 
anti-inflammatory cytokines interleukin 10 (IL-10) and interleukin 1 receptor antagonist 
(IL-1ra) (Steensberg et al., 2003). It has been suggested that chronic exercise may 
decrease systemic levels of pro-inflammatory mediators such as c-reactive protein (CRP), 
tumor necrosis factor α (TNF-α), and IL-6, but the reductions are modest at best (Shaw et 
al., 2015; Thomas et al., 2012). As such, a regular accumulation of acute bouts of aerobic 
exercise that result in consistent increases in systemic anti-inflammatory cytokines may 
be more important when it comes to the antitumor effects of exercise. Further, acute 
exercise can improve antitumor immunity by mobilizing highly cytotoxic natural killer 
(NK) cells to the tumor microenvironment in an epinephrine and IL-6 dependent manner 
(Pedersen et al., 2016). In order to facilitate antitumor immunity by cytotoxic immune 
cells, it will also be important to consider how exercise affects intratumoral immune 
suppression. 
For cancer patients receiving immunotherapy, it is imperative to elucidate 
methods that may reduce MDSC-related immune suppression. To date, no studies have 




Considering recent increases in the use of immunotherapies and a growing population of 
individuals living with cancer, it is imperative to answer questions surrounding the role 
exercise may play in modulating MDSCs. 
Statement of Purpose 
The purpose of this study was threefold: (a) to examine the effects of endurance 
exercise training on the time course of MDSC accumulation in a mouse tumor-bearing 
model, (b) to examine the effects of exercise on the suppressive quality of MDSCs in a 
mouse tumor-bearing model, and (c) examine the effects of exercise on lung metastasis in 
a mouse tumor-bearing model. 
Research Hypotheses 
H1 Endurance exercise training will delay the onset of MDSC accumulation 
in the spleen, blood, and tumor of tumor-bearing mice. 
 
H2 MDSCs harvested from exercised mice will have reduced suppressive 
quality. 
 
H3 Endurance exercise training will decrease the number of metastatic lesions 




Table 1 Abbreviations. 
Akt – protein kinase B 
Arg1 – arginase 1 
CRC - colorectal cancer 
CRP - c-reactive protein 
ECM – extracellular matrix 
EGF – epidermal growth factor 
EMT – epithelial mesenchymal transition 
FACS – fluorescence activated cell sorting 
GM-CSF - granulocyte-macrophage colony-
stimulating factor 
HGF – hepatocyte growth factor 
HIF-1α – hypoxia inducible factor-1α 
HMGB-1 – high mobility group protein 1 
IL-10 - interleukin 10 
IL-1β - interleukin-1β 
IL-1R - IL-1 receptor  
IL-1ra - interleukin 1 receptor antagonist 
IL-6 - interleukin-6 
MDSC – Myeloid-Derived Suppressor Cell 
MVPA – moderate-vigorous physical activity 
NK – natural killer cell 
NS – natural suppressor 
PA – physical activity 
TCR – T-cell receptor 
TGF-β – transforming growth factor β 
TME – tumor microenvironment 
TNF-α - tumor necrosis factor α 
ROS – reactive oxygen species 










REVIEW OF LITERATURE 
 Recent reports from the American Cancer Society project that more than 1.7 
million new cancer cases will occur in 2019 and over 600,000 people will die from 
cancer this year. Breast cancer incidence has remained relatively unchanged over the last 
decade and the obesity epidemic is one explanation for this observation (Cronin et al., 
2018; Heron & Anderson, 2016). Significant epidemiological data suggest there is a 
relationship between physical activity and reductions in cancer risk and mortality. For 
example, meeting the recommended 150 min/week of MVPA may reduce the risk for 
developing breast cancer by as much as 12% suggesting that breast cancer can be 
preventable with a change in lifestyle (Liu et al., 2016). MDSCs are a population of 
immune cells that expand in cancer patients and promote tumor progression through the 
suppression of antitumor immunity. Exercise has been shown to slow the progression of 
solid tumors in various pre-clinical animal models (Betof et al., 2015; Goh, Endicott, & 
Ladiges, 2014; Pedersen et al., 2016). Additionally, exercise can modulate the tumor 
microenvironment in a manner that facilitates invasion of cytotoxic immune cells and 
cancer therapies (Betof et al., 2015; Pedersen et al., 2016), however, its effects on 





 The 4T1 mammary carcinoma is a transplantable tumor cell line that was 
originally isolated in 1978. Four morphologically and karyotypically distinct sublines 
were isolated from a spontaneously arising mammary tumor in BALB/c mice (Dexter et 
al., 1978). All four sublines were shown to be tumorigenic in vivo and the 4T1 cell line 
was chosen for its selective resistance to thioguanine (Aslakson & Miller, 1992). Human 
breast cancers frequently present with mutations to the p53 tumor suppressor gene 
(Bertheau et al., 2013). The p53 protein is a potent regulator of the cell cycle and its 
modification and/or deletion results in uncontrolled cell growth. 4T1 cells have been 
described as p53 null (Yang et al., 2017; Yerlikaya, Okur, & Ulukaya, 2012) and also 
have constitutively active protein kinase B (Akt) (Xue et al., 2012), another common 
mutation frequently observed in human breast cancer. 
Regarding the experimental advantages of the 4T1 cell line, this cell line closely 
resembles the progression of human breast cancer as it is one of the few animal models of 
breast cancer that can spontaneously metastasize from the mammary fat pad (Aslakson & 
Miller, 1992; Pulaski & Ostrand-Rosenberg, 1998). The progression and metastatic 
pattern of 4T1 tumors closely resembles that of human breast cancer with a particular 
tropism for the lungs and liver (Pulaski & Ostrand-Rosenberg, 1998). Also, primary 4T1 
tumors can be easily established in the mammary gland of female BALB/c mice. Further, 
primary tumors can be surgically removed in order to study metastasis in an animal 
model that is similar to clinical models where primary tumors have been surgically 
removed (Pulaski & Ostrand-Rosenberg, 2001). Thioguanine resistance allows for the 




difficult experimentally. Organs from 4T1 tumor bearing mice can be harvested and 
cultured at specific time points, then treated with thioguanine, leaving only the metastatic 
drug resistant 4T1 colonies which can be fixed and quantified (Aslakson & Miller, 1992; 
Pulaski & Ostrand-Rosenberg, 1998; Pulaski & Ostrand-Rosenberg, 2001).  
The 4T1 tumor model has been used extensively to study the response of triple 
negative breast cancers to chemotherapy (Dalezis et al., 2017; Hu et al., 2017; Liu et al., 
2018) and immunotherapy (Du et al., 2017; Finke et al., 2011; Gebremeskel et al., 2017; 
Le et al., 2009; Ling et al., 2017; Liu et al., 2018; Noman et al., 2014). Moreover, 4T1 
tumors are known to stimulate production of MDSCs, which has made it a popular pre-
clinical model to study the role of intratumoral immune suppression on tumor progression 
and metastasis (Bunt, Sinha, Clements, Leips, & Ostrand-Rosenberg, 2006; Bunt et al., 
2007; Finke et al., 2011; Noman et al., 2014; Zhang et al., 2018). 
4T1 Tumors and Myeloid-Derived  
Suppressor Cells 
 
 4T1 tumors secrete many pro-inflammatory signals and chemokines that result in 
emergency myelopoiesis and the generation of MDSCs. In recent years the 4T1 tumor 
model has been one of the most common animal models used to study MDSC biology. 
Bunt and colleagues (2007) investigated the effects of chronic inflammation on MDSC 
accumulation and tumor progression (Bunt et al., 2007). 4T1 tumors were implanted into 
IL-1 receptor (IL-1R)-deficient mice, which have lower potential for inflammation, and 
IL-1ra-deficient mice, which have increased potential for inflammation. MDSC 
accumulation was significantly delayed in IL-1R-deficient mice which resulted in 
reduced tumor progression compared to IL-1ra-deficient mice. Additionally, IL-6 




suggest that chronic inflammatory signaling from IL-1β and IL-6 is one of the driving 
forces behind the accumulation of MDSCs. 
 Chronic inflammation, which is common among many cancers, has also been 
shown to promote survival of MDSCs. One study used proteomic analysis to identify 
proteins expressed in the highly inflammatory 4T1 tumor environment (Chornoguz et al., 
2011). They found that the Fas pathway and caspase proteins were likely candidates that 
could explain resistance to apoptosis in MDSCs. Inflammation-induced MDSCs showed 
significantly lower levels of activated caspases following treatment with a Fas agonist 
suggesting that an inflammatory environment protects MDSCs from extrinsic apoptosis 
signals and results in increased half-life of MDSCs. Taken together, these results support 
the hypothesis that inflammation is a driving force for the accumulation and survival of 
MDSCs, which promote 4T1 tumor progression through the suppression of antitumor 
immunity. 
Myeloid-Derived Suppressor Cells 
 MDSCs are most frequently described as a heterogeneous population of immature 
immune cells that suppress innate and adaptive immune responses. These cells were 
originally discovered in the 1970’s and described as natural suppressor (NS) cells 
(Bennett, Srinivasa Rao, & Mitchell, 1978). In mice, two subtypes of MDSCs have been 
identified; monocytic MDSCs (M-MDSC) and polymorphonuclear MDSCs (PMN-
MDSC). M-MDSCs are defined as CD11b+Ly6G–Ly6Chi and PMN-MDSCs are defined 
as CD11b+Ly6G+Ly6Clo (Youn et al., 2008). The phenotypic profile of these cells was, 
and still is, contentious due to the heterogeneity of these cells and the common markers 




2013). Nonetheless, there has been increasing interest in immunosuppressive cells of 
myeloid origin due to their role in tumor progression. Due to the lack of well-defined 
nomenclature, Gabrilovich and colleagues (2007) suggested that these cells be called 
“myeloid-derived suppressor cells” to reflect their origin and function and facilitate 
further scientific discussion and progress (Gabrilovich et al., 2007). Although some still 
debate the phenotype of these cells, it is now accepted that suppressive cells of myeloid 
origin play a critical role in the progression of cancer. 
Myeloid-Derived Suppressor Cells:  
Generation and Accumulation 
 
 Chronic inflammation is one of the hallmarks of cancer and it is now well 
established that tumor-produced inflammatory signals promote the accumulation of 
MDSCs with potent suppressive activity. For example, high levels of GM-CSF, which is 
a common chemokine expressed in 4T1 tumors (Finke et al., 2011), has been shown to 
stimulate production of MDSCs that inhibit antigen-specific T-cell responses (Morales et 
al., 2010; Serafini et al., 2004). Additionally, Sceneay and colleagues were able to 
demonstrate that bone marrow cells cultured with IL-6 and GM-CSF results in the 
generation of MDSCs that are phenotypically and functionally similar to MDSCs from 
tumor bearing mice (Sceneay et al., 2018). Furthermore, vascular endothelial growth 
factor (VEGF) expression is frequently increased in hypoxic tumor environments and 
VEGF has been shown to be a chemoattractant for MDSCs (Gabrilovich et al., 1996; 
Kusmartsev et al., 2014). Pre-clinical studies using mice have demonstrated that a variety 
of pro-inflammatory signals drive MDSCs accumulation. 
IL-6 and IL-1β are two pro-inflammatory cytokines that have frequently been 




overexpression of IL-1β in 4T1 tumors decreased survival time and elevated levels of 
MDSCs in tumor bearing mice (Bunt et al., 2006). This suggests there is a relationship 
between IL-1β and IL-6 signaling in the generation of MDSCs. For instance, 
administering IL-6 in IL-1R-deficient mice harboring 4T1 tumors restores MDSCs and 
hastens tumor progression (Bunt et al., 2007) suggesting that IL-6 is downstream of IL-
1β. Additionally, TNF-α, another proinflammatory cytokine commonly found in the 
tumor microenvironment, also promotes the accumulation of MDSCs. Pharmacological 
inhibition of TNF-α has been shown to facilitate the differentiation of MDSCs into 
dendritic cells and macrophages (Sade-Feldman et al., 2013). Collectively, the results of 
these studies suggest that chronic inflammatory signals such as IL-1β and TNF-α may 
stimulate the release of IL-6 and GM-CSF from other cell types such as macrophages, 
which in turn promotes MDSC generation in the bone marrow. 
Myeloid-Derived Suppressor Cells:  
Mechanisms of Immune  
Suppression 
 
 Multiple mechanisms are involved in immune suppression by MDSCs. The 
primary mechanisms that have been described involve the depletion of key nutrients 
involved in T-cell proliferation and the generation of oxidative stress that affects T-cell 
trafficking and activation. Overexpression and/or production of arginase 1 (Arg1) 
(Highfill et al., 2010), nitric oxide synthase  (Arina & Bronte, 2015), hydrogen peroxide, 
superoxide (Corzo et al., 2009), and peroxynitrite (Nagaraj et al., 2007) are some of the 
key phenotypical and functional characteristics of MDSCs. The mechanisms listed above 




challenges with isolating MDSCs from tumors at a high enough frequency that allows for 
functional assessment (Kumar, Patel, Tcyganov, & Gabrilovich, 2016). 
 Arg1 catalyzes the following reaction: L-arginine + H2O → ornithine + urea and 
the overexpression of Arg1 in MDSCs leads to significant depletion of L-arginine (Atkins 
et al., 2009; Raber, Ochoa, & Rodríguez, 2012; Rodriguez et al., 2005). L-arginine is an 
amino acid used in the biosynthesis of proteins and has been shown to be important for T-
cell proliferation and function. For example, Zea et al. demonstrated that T-cells activated 
in vitro in the absence of L-arginine had decreased expression of CD3, an important co-
receptor in the T-cell receptor (TCR) complex that generates activation signals in T-cells 
(Zea et al., 2004). Additionally, T-cells cultured in the absence of L-arginine are arrested 
in the G0-G1 phase of the cell cycle, while cells cultured with L-arginine progress 
through to the M phase (Rodriguez, Quiceno, & Ochoa, 2007). Therefore, the 
overexpression of Arg1 in MDSCs and depletion of L-arginine presents a major barrier to 
T-cell proliferation and activation in tumor bearing individuals. 
 MDSCs generate a significant amount of oxidative stress through their production 
of reactive oxygen species (ROS). This is accomplished primarily by an increased 
expression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase which 
catalyzes the production of a superoxide free radical by transferring an electron to oxygen 
from NADPH. Increased expression of NADPH oxidase in MDSCs causes large amounts 
of ROS to be released, which inhibits activation of T-cells (Corzo et al., 2009; Huang et 
al., 2013). Specifically, when MDSCs are in close proximity to T-cells, nitration of the 
TCR and/or CD8 receptor alters the conformation of the protein resulting in significantly 




and nitration of the TCR represent two of the primary mechanisms by which MDSCs 
exert their immunosuppressive effects on adaptive immune cells. 
Myeloid-Derived Suppressor Cells  
and Metastasis 
 
 Evidence exists for a role of MDSCs in the majority, if not all, steps that lead to 
the development of metastatic disease. MDSCs employ numerous mechanisms that 
facilitate invasion of tumor cells into surrounding tissue and seeding in distant organs. 
Clinically, high levels of MDSCs have been correlated with an increase in metastasis in 
the lymph nodes of breast cancer patients (Yu, Wang, Yan, Li, & Ren, 2013). 
Additionally, MDSCs are correlated with increased metastasis in several other cancer 
types including non-small cell lung cancer (Huang et al., 2013) and melanoma (Weide et 
al., 2014). Consequently, there has been increasing interest in uncovering the 
mechanisms utilized by MDSCs that promote metastasis. 
 The current research suggests that MDSCs can be recruited to the pre-metastatic 
site before tumor cells and facilitate tumor seeding by creating an immunosuppressive 
environment. Additionally, MDSCs contribute to tumor invasion by promoting 
neovascularization, degradation of the extracellular matrix (ECM), and may even be 
involved in the epithelial-mesenchymal transition (EMT) (Condamine, Ramachandran, 
Youn, & Gabrilovich, 2014; Safarzadeh, Orangi, Mohammadi, Babaie, & Baradaran, 
2018). For example, the chemokines CXCL1, CXCL2, and CXCL5 recruit MDSCs to the 
pre-metastatic site and enhance the survival of tumor cells when they arrive by creating 
an immunosuppressive environment (Acharyya et al., 2012; Connolly et al., 2009; Toh et 




MDSCs that enhances tumor seeding in distant organs through the formation of a pre-
metastatic niche. 
Neovascularization is important for tumor progression and metastatic 
dissemination. Naturally, MDSCs appear to be involved in this process. For instance, 
rapid tumor growth results in hypoxia and up-regulation of proangiogenic factors that 
enhance MDSC recruitment to the tumor microenvironment via hypoxia inducible factor-
1α (HIF-1α) (Noman et al., 2014; Qian et al., 2019). Also, MDSCs secrete matrix 
metalloproteinases (MMP) that degrade the ECM and increase bioavailability of VEGF 
to stimulate blood vessel formation in the tumor (Safarzadeh et al., 2018). Further, Shen 
and colleagues (2014) showed that activated MDSCs secrete VEGF which contributes to 
the formation of new blood vessels (Shen, Wang, He, Wang, & Zheng, 2014). In general, 
these data suggest that MDSCs play a role in the neovascularization of solid tumors 
through the production of various pro-angiogenic factors and degradation of the ECM.   
Finally, it has been shown that MDSCs play a role in EMT, a critical step in 
tumor invasion and metastasis. EMT represents a loss of cell-cell adhesion and 
downregulation of E-cadherin which allows for invasion into the basement membrane 
and intravasation into the blood stream. In some cases, tumor cells appear to acquire this 
motile phenotype through various chemical signals rather than selective, random 
mutations. For example, Toh et al. (2011) demonstrated that purified MDSCs induce 
EMT in cancer cells through the secretion of transforming growth factor β (TGF-β), 
epidermal growth factor (EGF), and hepatocyte growth factor (HGF) (Toh et al., 2011). 




transcription factors such as nuclear factor-B (NF-B) and Snail through the secretion 
of high mobility group protein 1 (HMGB-1) (Simpson, Templeton, & Cross, 2012).  
Aerobic Exercise and Cancer 
 Significant epidemiological data exists suggesting that physical activity reduces 
the risk for developing cancer. The overall risk of cancer may be reduced by 7% in 
individuals who meet the current WHO recommendations for physical activity, which is 
150 min/week of MVPA or 10 MET-hours/week. Breast cancer seems to be particularly 
responsive to physical activity as both premenopausal and postmenopausal women who 
are physically active have a relative risk (RR) of 0.79 and 0.89 respectively (Liu et al., 
2016). The benefits of regular physical activity also show a dose-dependent response. 
That is, increased amounts of exercise above the minimum recommended amount by the 
WHO show increased protection against the development of cancer (Liu et al., 2011; 
Ruiz-Casado et al., 2017). Cancer risk decreases by 1% for every additional 20 MET-
hours/week above 20 MET-hours/week (Liu et al., 2016). Additionally, risk of mortality 
due to breast cancer is significantly lower in physically active individuals. When 
comparing the highest vs. lowest levels of PA, RR of breast cancer mortality is 0.77 for 
pre-diagnosis PA and 0.72 for post-diagnosis PA (Schmid & Leitzmann, 2014). Current 
mechanisms that may explain the protection of exercise on cancer development and 
mortality include a combination of reduced systemic cancer risk factors and accumulation 
of anticancer components following acute bouts of exercise. 
Effects of Exercise on Tumorigenesis 
 It is now well established that physical inactivity is a major risk factor for the 




investigated the effects of exercise on tumorigenesis in pre-clinical animal models. 
Although differences exist between tumor types depending on the tissue of origin, most 
solid tumors utilize oncogenic pathways that allow for overproduction of inflammatory 
signals, immune system evasion, promotion of angiogenesis, and apoptosis resistance. 
Exercise has the potential to affect the variables listed above and has consequently 
become the primary focus of current research. 
 Recently, Pedersen and colleagues showed that voluntary wheel running in mice 
reduced tumor growth by as much as 60% across five different tumor models (Pedersen 
et al., 2016). This reduction in tumor growth was associated with an epinephrine and IL-
6-dependent mobilization of NK cells to the tumor microenvironment as blockade of 
these signaling pathways negated the effects of exercise on tumor growth. In agreement 
with these results, Betof et al. demonstrated that wheel running in Balb/c mice bearing 
4T1 tumors significantly reduced tumor growth (Betof et al., 2015). Exercise led to an 
increase in tumor cell apoptosis, improved blood vessel maturity, and reduced hypoxia in 
these animals. Additionally, Buss and Dachs (2018) showed that voluntary exercise can 
decrease tumor hypoxia, which led to a decrease in tumor growth (Buss & Dachs, 2018). 
Further, wheel running and treadmill training in mice can reduce intratumoral IL-6 and 
VEGF (Amani Shalamzari et al., 2014), increase TNF-α in tumor tissue (Molanouri 
Shamsi et al., 2019), and slow tumor growth in a distance-dependent manner (Goh et al., 
2014). In summary, exercise in tumor bearing mice can promote blood vessel maturation 
that leads to reductions in intratumoral hypoxia and facilitates infiltration of cytotoxic 




recruitment of pro-tumor immune cells may be reduced in the tumor which would 
improve immune detection by cytotoxic immune cells. 
Effects of Exercise on Inflammation 
 As described above, tumor-associated inflammation drives cancer progression 
through the recruitment of immunosuppressive MDSCs that allow for evasion of immune 
surveillance. Pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α have been 
shown to regulate MDSC recruitment from the bone marrow. Additionally, CRP is an 
acute phase protein released in response to IL-6 and TNF-α that is associated with poorer 
prognosis in breast cancer patients (Allin, Nordestgaard, Flyger, & Bojesen, 2011). 
Exercise has shown to affect these signaling pathways, and thus has the potential to 
temper tumor-induced immune suppression. Various studies have examined the effects of 
exercise training on systemic inflammatory signals with both chronic and acute exercise. 
 Systemic CRP is one of the most frequently measured inflammatory markers 
following exercise training. Chronic exercise interventions have been shown to 
significantly decrease systemic CRP levels following training (Fairey et al., 2005; 
Friedenreich et al., 2012). Additionally, highly trained individuals present with low levels 
of circulating CRP compared to sedentary controls. For example, Tomaszewski and 
colleagues (2003) showed that CRP concentrations in male ultramarathon runners were 
less than half that of controls (Tomaszewski et al., 2003). Systemic decreases in CRP 
levels appear to be the most prominent when the exercise intervention exceeds 4 months 
(Campbell et al., 2009; Dethlefsen et al., 2017), providing evidence for the importance of 
lifelong physical activity for cancer prevention. There is limited data examining CRP 




CRP following exercise intervention (Gómez et al., 2011; Guinan et al., 2013; Rogers et 
al., 2013).  It should be noted that many of these studies involved only 8-12 weeks of 
exercise. However, a recent study demonstrated that in a population of cancer survivors 
engaged in exercise-based rehabilitation, those with low plasma CRP concentrations had 
a significantly higher levels of cardiorespiratory fitness compared to those with 
moderate/high concentrations of plasma CRP (Christensen et al., 2019). 
 The effects of chronic exercise on levels of IL-6 and TNF-α are much more 
varied. Some studies have shown a significant decrease in IL-6 and TNF-α (Balducci et 
al., 2010; Kullo, Khaleghi, & Hensrud, 2006; Shanely et al., 2013) while others show no 
effect of exercise (Friedenreich et al., 2012; Libardi, De Souza, Cavaglieri, Madruga, & 
Chacon-Mikahil, 2012). Further, a meta-analysis of over 150 studies showed that IL-6 
and TNF-α concentrations were unchanged with exercise in individuals without a cancer 
diagnosis (Lin et al., 2015). Similarly, a meta-analysis of exercise interventions in breast 
cancer patients showed no effect of training on IL-6 and TNF-α levels (Kang et al., 
2017). Again, most of these interventions were of a relatively short duration suggesting 
that the most pronounced effects of chronic exercise on systemic inflammatory markers 
require longer periods of training. 
 Many studies have investigated the chronic effects of exercise on systemic 
inflammation and cancer risk factors, yet the acute effects of exercise on tumor biology 
remain a somewhat neglected area of research. However, several preclinical studies have 
shown that exercise-conditioned serum following acute exercise can directly inhibit the 
growth of cancer cells in vitro (Dethlefsen et al., 2016; Gannon, Vaughan, Garcia-Smith, 




established that IL-6 significantly increases following acute bouts of exercise evident by 
a >10 fold increase following prolonged bouts of PA (Pedersen & Febbraio, 2012). 
Unlike IL-6 secreted from immune cells in response to pro-inflammatory signals such as 
TNF-α, this is generally considered an anti-inflammatory response due to the acute 
induction of anti-inflammatory cytokines. For example, infusion of IL-6 does not 
increase levels of the pro-inflammatory cytokine TNF-α while enhancing the plasma 
levels of the anti-inflammatory cytokines IL-1ra and IL-10 (Steensberg et al., 2003). 
Additionally, Nieman et al. (2006) reported that there is a 2.7-fold increase in blood 
leukocyte IL-10 mRNA and a 2.2-fold increase in blood leukocyte IL-1ra mRNA 1-hour 
post-exercise (Nieman et al., 2006). Further, this anti-inflammatory milieu is maintained 
for several hours following exercise (Mendham, Duffield, Marino, & Coutts, 2015). 
These data suggest that both long-term training and the accumulation of repeated bouts of 
acute exercise are important for the anti-inflammatory effects of exercise. The 
accumulated surge of anti-inflammatory cytokines following acute exercise may also 
directly counteract pro-inflammatory signals that are frequently associated with MDSC 
induction and tumor progression such as IL-1β and pro-inflammatory IL-6.  
Effects of Exercise on Metastasis 
 Metastatic disease is the primary cause of cancer-related deaths. As described 
above, regular physical activity can reduce the risk for mortality due to cancer by as 
much as 20% (Schmid & Leitzmann, 2014). Therefore, it has been hypothesized that 
exercise may decrease the dissemination of tumor cells to distant organs. Indeed, there 
have been several studies investigating the effects of exercise on metastasis, however, 




example, many studies use intravenous (tail-vein) injection of tumor cells (Hoffmann-
Goetz, MacNeil, & Arumugam, 1994; Jadeski & Hoffman-Goetz, 1996; MacNeil & 
Hoffman-Goetz, 1993; Pedersen et al., 2016), while others investigate metastasis arising 
from the primary tumor (Dethlefsen et al., 2016; Gershbein, Benuck, & Shurrager, 1974). 
Intravenous injection of tumor cells allows for evaluation of the ability of circulating 
tumor cells to survive and colonize in an organ, however it does not allow for 
investigation of the early steps in the metastatic cascade. Thus, the most appropriate 
model of metastasis is orthotopic primary tumors that spontaneously metastasize to 
distant organs. 
 Concerning the effects of exercise on metastasis, it is difficult to make meaningful 
comparisons between studies due to differences in tumor models and exercise protocols. 
In models of metastasis that arise from primary tumors, most studies show no effect of 
exercise. For instance, Jones et al. (2012) used voluntary wheel running in mice 
orthotopically injected with C-1 prostate cancer cells and showed a non-significant 
decrease (34%) in the number of metastatic lesions.  In support of these results, Yan and 
colleagues (2011) demonstrated that there was a non-significant trend toward a decrease 
in tumor metastasis with voluntary wheel running after surgical resection of Lewis lung 
carcinoma tumors (Yan & Demars, 2011). Conversely, a recent study showed that 
pulmonary metastasis was increased with voluntary wheel running in the 4T1 tumor 
model (Smeda et al., 2017). Further, studies using intravenous injection of tumor cells 
have shown that exercise can decrease radioactivity in the lungs from radiolabeled tumor 
cells (Hoffmann-Goetz, MacNeil, & Arumugam, 1994), decrease tumor cell retention in 




lungs (Pedersen et al., 2016). These data suggest that exercise has minimal effects on 
tumor metastasis, however differences in training modality, tumor model, and 
quantification of metastases make it difficult to make definitive conclusions. Therefore, 
more studies using orthotopic tumor models are needed. 
Summary 
 Breast cancer incidence remains relatively unchanged and is largely attributed to 
worldwide increases in lifespan, physical inactivity and obesity. Consequently, a 
significant number of people are living with breast cancer. While a large body of 
evidence suggests that regular PA can reduce cancer risk and mortality, the biological 
mechanisms explaining this relationship remain unclear. Tumor progression is driven in 
part by chronic inflammation that results in the generation of pro-tumor MDSCs. MDSCs 
inhibit antitumor immunity, promote metastasis, and reduce the efficacy of 
immunotherapy. Pre-clinical studies show that exercise has the potential to slow tumor 
growth by normalizing tumor vasculature, which reduces intratumoral hypoxia and 
facilitates infiltration of cytotoxic immune cells. Additionally, exercise can reduce 
systemic inflammation and promote an anti-inflammatory phenotype following acute 
exercise. The anti-inflammatory effects of exercise have the potential to directly oppose 
signals that have been implicated in MDSC generation, yet no studies have investigated 










 This study utilized endurance training to examine the effects of exercise on 
MDSC-related tumor progression and metastasis in an orthotopic mouse model of breast 
cancer. The primary purpose of this study was to determine if exercise temporally delays 
the onset of MDSC accumulation in the blood, spleen, and tumor of tumor-bearing mice. 
A secondary purpose of this study was to examine the effects of exercise on MDSC 
function by measuring the suppressive quality of these cells in vitro. The final purpose of 
this study was to determine the effects of exercise on lung metastasis. These exercise 
effects were evaluated using a 10-week endurance exercise voluntary wheel running 
protocol. On the 6th week of the training protocol, animals were inoculated with 1x104 
4T1 tumor cells in the dorsal mammary fat pad and then continued to train for an 
additional 4 weeks. Subgroups were sacrificed at varying time points following tumor 
inoculation to examine the time course of MDSC accumulation. Figure 1 outlines the 
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Figure 1. Experimental Design. WR, wheel run; SED, sedentary; TUM, tumor. 
WR+TUM groups, n = 10 per time point. SED+TUM groups, n = 10 per time point. 
Animals and Animal Care 
 Female Balb/c mice (n = 80) were housed individually in a temperature-controlled 
facility with a 12:12 hour light-dark schedule. Additionally, female age-matched non-
tumor control mice (n = 20) were used to harvest naïve splenocytes for T-cell suppression 
assays. Mice were given standard chow and distilled water ad libitum. All procedures 
were approved by the University of Northern Colorado’s Institutional Animal Care and 
Use Committee (IACUC) and were in compliance with the Animal Welfare Act 
guidelines. 
Exercise Training Protocol 
Mice, 8 weeks of age, were randomly assigned to either a wheel run (WR+TUM) 
or sedentary (SED+TUM) group on day one of the exercise intervention. SED+TUM was 
restricted to normal cage activity for the duration of the study. WR+TUM animals were 
given 24-hour access to commercially available running wheels (11.5 cm by diameter) 
(MiniMitter; Bend, OR) for the duration of the study. Running distance was monitored 










Cell Culture, Tumor Inoculation, 
and Measurement 
 The 4T1 mouse mammary carcinoma (ATCC, Manassas, VA) cell line was used 
to establish orthotopic tumors in the mammary gland. Cells were grown in Roswell Park 
Memorial Institute (RPMI) medium supplemented with 10% fetal bovine serum (FBS) 
and maintained in a humidified incubator with 5% CO2. Cell growth medium was 
replaced every two to three days.  
On week 6 of the study, animals were sedated with isoflurane and inoculated 
subcutaneously with 1x104 4T1 cells suspended in 100 µl of PBS in the fourth mammary 
gland on the right side using a 25-gauge syringe needle. Mice were the most active from 
8:00 PM – 8:00 AM during this study. Therefore, to ensure that injections were 
performed during a period of reduced activity, all tumor inoculations occurred between 
11:00 AM and 1:00 PM. Following tumor inoculation, SED+TUM and WR+TUM were 
randomly subdivided into different time point groups: 16 days (n = 10), 20 days (n = 10), 
24 days (n = 10), or 28 days (n =10).  Previous unpublished data in our lab demonstrated 
that mice injected with 1x104 4T1 cells develop palpable tumors after 8 days on average. 
Also, these tumors become measurable with digital calipers after 14 days on average. 
Although tumors are present well before the 16-day time point, it is unlikely that enough 
cells could be harvested for flow cytometric analysis. Thus, the earliest time point of 16 
days was chosen. Additionally, pilot data from our lab indicate that MDSCs are not 
present in the tumor or peripheral lymphoid organs by 12 days post-tumor injection, 
making functional analysis of these cells impossible. For additional time-points of 
sacrifice, 4-day intervals were chosen because previous data have shown that 4T1 tumors 




Subgroups of mice were sacrificed at the specified time points post-injection. Body 
condition, and tumor volume was monitored three times per week for the duration of the 
study. Tumor length and width was measured using digital calipers. These measurements 
were used to estimate tumor volume using the following formula: π/6 × width × length2, 
where length equals the largest diameter, and width was measured 90° from length.  
Flow Cytometry 
Tissue Preparation and Analysis 
 Spleen, blood, and tumor samples were harvested and prepared for flow 
cytometry. Spleens were mechanically dissociated using the frosted end of two 
microscope slides and filtered through a 100 µm cell strainer. Blood samples were 
collected via cardiac puncture into a syringe containing 0.1 mL heparin. Tumors were 
excised and mechanically homogenized using a cell dissociation sieve tissue grinder 
(Sigma Aldrich), then enzymatically digested in type IV collagenase (2 mg/mL) and 
DNase (100 µg/mL) for 45 minutes at 37°C on a platform rocker. Following digestion, 
tumor samples were filtered through a 100 µm cell strainer. Single cell suspensions of 
splenocytes, tumor, and peripheral blood were cleared of red blood cells (RBC) by 
incubating in ammonium-chloride-potassium lysis buffer for 3 minutes at room 
temperature. Fc receptors were blocked by incubating samples on ice for 10 minutes in 
anti-mouse CD16/32 antibody (BioLegend). Cells were then resuspended in antibody 
solution containing fluorochrome-conjugated monoclonal antibody against CD11b, Ly-
6G, Ly-6C, or the appropriate isotype control (BioLegend). Samples were incubated on 
ice, in the dark, for 35 minutes and analyzed on an Attune NxT flow cytometer. Initial 




Unstained and isotype controls were used to exclude background fluorescence and ensure 
there is no evidence of non-specific binding. Proportions of MDSCs were quantified in 
the blood, spleen, and tumor and were reported as total MDSCs as a percentage of the 
total cells in the sample. A representative example of the gating strategy used to identify 
MDSCs is provided in Appendix B. 
Myeloid-Derived Suppressor Cell 
Sorting Using Fluorescence 
Activated Cell Sorting 
 
 PMN-MDSCs and M-MDSCs were purified from the spleens of tumor bearing 
mice for functional assessment using fluorescence activated cell sorting (FACS). Single 
cell suspensions of splenocytes were cleared of red blood cells and stained with zombie 
violet viability dye (BioLegend) for 15 min according to manufacturer recommendations. 
Next, cells were stained for CD11b, Ly-6G, and Ly-6C as described above. Gates were 
established to identify zombie violet negative (viable) cells, then CD11b+Ly6G+Ly6Clo 
and CD11b+Ly6G-Ly6Chi cells for sorting. These subpopulations of MDSCs were pooled 
and sorted into the same 15 mL conical containing complete RPMI (cRPMI) 
supplemented with 20% FBS using a SH800S cell sorter. After sorting, cells were 
centrifuged for 7 minutes at 300g. The cell pellet was resuspended in cRPMI growth 
medium at a concentration of 1x106/mL and set aside. 
T-cell Suppression Assay 
Antibody Coating of Microwell Plates 
Anti-CD3 antibody was prepared in sterile PBS (5 µg/mL) and 50 µL was 
dispensed into each experimental well of a 96-well flat-bottom tissue culture plate. Fifty 




with Parafilm and incubated for 2 hours at 37oC. Before adding cells, antibody solution 
was removed, and each well was washed 2 times with sterile PBS. 
Addition of Cells 
All samples used for the T-cell suppression assay were handled under sterile 
conditions. Splenocytes were harvested from a naïve female Balb/c mouse, 12-15 weeks 
of age, and cleared of red blood cells as described above. The cell suspension was 
resuspended in cRPMI at a concentration of 2x106/mL and centrifuged for 7 minutes at 
300g. The cell pellet was then resuspended in CellTrace Violet (1:1000) and incubated at 
37oC for 20 minutes protected from light. CellTrace Violet was quenched by adding 
cRPMI and incubating cells for an additional 5 minutes at 37oC. Cells were pelleted and 
resuspended in cRPMI. Next, 100 µL of the splenocyte cell suspension (2x105 total cells) 
was added to each well. One hundred µL of the MDSC suspension (1x105 total cells) was 
added to each experimental well for a 2:1 splenocyte to suppressor ratio. To account for 
higher cell numbers and added competition for resources in the experimental wells, 3x105 
splenocytes were added to control wells to equal the total number of cells in experimental 
wells. One hundred µL of cRPMI was added to unstimulated control and stimulated 
control wells for a final volume of 200 µL/well. Next, soluble anti-CD28 (2 µg/mL) 
antibody was added to each stimulated well. Finally, samples were incubated at 37oC for 
72 hours and analyzed on an Attune NxT flow cytometer.   
Figure 2 outlines an example of the setup of control and experimental wells. 
Representative results from dye dilution analysis are presented in Figure 3. The peak 
farthest to the right, which has the highest fluorescence of CellTrace Violet, represents 




more times. CellTrace fluorescence decreases (becomes more dilute) with multiple cell 
divisions. Using the FCS express software, a proliferation index can be calculated from 
this histogram which is the average number of divisions of responding cells. The 
proliferation index should be lower in splenocytes co-cultured with MDSCs. 
 
Figure 2. T-cell suppression assay design. Theoretical setup of a culture dish for 
functional assessment of MDSCs from an individual animal run in duplicate. All 
splenocytes were labeled with CellTrace Violet for detection of proliferation via dye 
dilution. Stimulated wells were coated with anti-CD3 antibody and soluble anti-CD28 
antibody for activation of CD3+CD28+ T-cells. MDSCs were isolated from individual 






Figure 3. Detection of cell division by dye dilution. Cells were stained with CellTrace 
Violet and stimulated with CD3 antibody. The peak outlined in black are cells that have 




 An incision was made along the midline of the abdomen through the ribcage and 
up toward the salivary glands. The trachea was identified and elevated by threading a 
pipette tip underneath. Using a 27-G syringe needle, India Ink (10% India Ink and 0.1% 
ammonium hydroxide) was injected into the lungs via the trachea until resistance was 
felt. The trachea was cut, and the lungs were removed. Lungs were rinsed briefly with 
deionized water and transferred to a glass vial containing 3 mL of Fekete’s solution (50% 
ethanol, 6% formaldehyde, 3% glacial acetic acid). After at least 10 minutes, tumor 
nodules were visualized as white dots on black lungs (Figure 8B). Lungs were transferred 
to a dish and individual white dots were counted as a single metastatic tumor nodule 
(Paschall & Liu, 2016). Metastatic nodules were manually counted on the surface of both 




average surface nodule count was obtained for each group. Group averages were 
compared to determine the effects of exercise on the number of metastatic lung nodules. 
Statistical Analysis 
 All data are presented as means ± standard error of the mean. For tissue-resident 
MDSC proportions, a student’s t test was used to identify group differences for the 
number of MDSCs in spleen, blood or tumor samples. For tumor volume, tumor mass, 
and metastatic lung nodules, student’s t tests were performed for the specified time points 
to determine group differences. If variances were significantly different, a t test with 
Welch’s correction was used. For T-cell proliferation, repeated measures ANOVA was 
used to identify differences between stimulated controls, and co-cultures containing 
MDSCs harvested from SED+TUM or EX+TUM. P-values with p < 0.05 were 










 A total of 7 animals (SED+TUM day 16, 20, 24, and 28, n = 1/timepoint; 
WR+TUM day 16, 24, and 28, n = 1/timepoint) were euthanized early and excluded from 
analysis due to poor body condition as a result of tumor growth during this study. No 
differences were observed between groups for initial body mass or final body mass over 
the course of the study (Figure 4). Additionally, no differences were observed in running 
distance between different timepoint groups (Figure 5). This is expected as mice tend to 
run more during the first weeks of being housed in a wheel running cage and 
progressively decrease their running volume each subsequent week, resulting in only 
slightly higher post-injection distances in the 24 and 28 day groups (Turner, Kleeberger, 





Figure 4. Body Mass. Day 0 represents initial body mass for all animals included in the 
study (n = 40/group). Day 16-28 points represents final body mass at the corresponding 





Figure 5. Running distance in WR+TUM animals. (A) Pre-tumor running distance, (B) 









Myeloid-Derived Suppressor Cell Accumulation  
and Tumor Progression 
 
 Spleen, blood, and tumor samples were analyzed in tumor-bearing mice at the 
indicated time points to determine the effects of physical activity on MDSC 
accumulation. At day 16, a marked increase in the number of these cells was observed in 
tumor bearing animals. In WR+TUM animals, MDSCs in the spleen were significantly (p 
< 0.05) lower than SED+TUM at day 16 (23.0 ± 10.0% vs. 33.0 ± 5.2%) and day 20 
(24.3 ± 5.1% vs. 33.9 ± 8.0%) (Figure 6A). The effect of exercise on MDSC 
accumulation in the spleen was lost by day 24 and 28 as no differences were observed 
between groups. Additionally, at day 16, circulating MDSCs in the blood were 
significantly lower (p < 0.05) in WR+TUM (14.7 ± 8.5%) when compared to SED+TUM 
(23.2 ± 7.1%) (Figure 6B). Interestingly, it appears that MDSCs do not begin to infiltrate 
4T1 tumors until the later stages of progression. While MDSC populations increased in 
the spleen and blood by day 16, MDSC levels in the tumor remained relatively low until 
day 28. A recent study showed that a combination of physical activity and energy 
restriction reduced total MDSCs in the tumor microenvironment (TME) 35 days post-
tumor implantation by about 15% (Turbitt et al., 2019). In comparison, we observed a 
non-significant (p = 0.08) 24% decrease in MDSCs in the TME of WR+TUM (17.2 ± 
5.3%) when compared to SED+TUM (23.2 ± 8.7%) at day 28 independent of energy 
restriction (Figure 6C). While the delay in accumulation of MDSCs did not translate to 
smaller tumors at any timepoint (Figure 7), there was a non-significant 62% and 26% 
reduction in metastatic lung nodules in WR+TUM at days 24 and 28, respectively (Figure 
8A). Spleen mass progressively increased as tumor size increased, and no differences 





Figure 6. MDSC accumulation. (A) Total accumulation of MDSCs in the spleen (B) 
blood, and (C) tumor at the specified time-points post-4T1 cell injection. Means ± SEM. 







Figure 7. Tumor mass. Progression of tumor mass over the course of the study. Means ± 
SEM. A student’s t test was used to compare groups at each respective timepoint post-




Figure 8. Metastatic lung nodules. (A) Progression of the absolute number of metastatic 
lung nodules over the course of the study. (B) Representative lung samples from day 28 
animals showing visualization of white nodules on black lungs. Means ± SEM. A 






Figure 9. Spleen mass. Progression of spleen mass over the course of the study. Means ± 
SEM. A student’s t test was used to compare groups at each respective timepoint post-
4T1 cell injection. 
 
T-cell Suppression Assay 
 MDSCs were identified and purified from the spleen using FACS. Representative 
samples from the spleen of an individual WR+TUM animal at day 28 before sorting and 
after sorting are presented in Figure 10. Average purity of all sorted samples was >80%, 
which is within the normal expected range when using this method (Solito et al., 2019). 
Pathological activation of MDSCs has been described previously as a gradual process 
that is related to tumor progression (Gabrilovich, 2018). The results presented here 
support this idea as MDSCs purified from tumor bearing mice did not become 
significantly suppressive toward T-cell proliferation until day 28. CD3+CD4+ T-cell 




lower (p < 0.05) than stimulated control samples (5.30 ± 0.53) (Figure 11A). In 
comparison, CD3+CD4+ cell proliferation index in WR+TUM MDSC co-cultures (5.05 ± 
0.59) was not significantly suppressed suggesting that endurance exercise delayed the 
acquisition of suppressive function by MDSCs. At all timepoints, CD3+CD8+ T-cell 
proliferation was not significantly suppressed in either group (Figure 11B). However, 
CD3+CD8+ T-cell proliferation in WR+TUM co-cultures (5.54 ± 0.53) at day 24 was 
significantly higher (p < 0.05) than stimulated controls (4.04 ± 0.69) suggesting that these 
cells were potentially promoting CD3+CD8+ T-cell proliferation. 
 
Figure 10. Gating strategy for MDSC purification using FACS. (A) Spleen sample from 






Figure 11. T-cell suppression assay in MDSC co-cultures. (A) CD3+CD4+ T-cell 
proliferation in stimulated controls and MDSC co-cultures at the specified timepoint 
post-4T1 cell injection. (B) CD3+CD8+ T-cell proliferation in stimulated controls and 
MDSC co-cultures at the specified timepoint post-4T1 cell injection. (C) Representative 
CD3+CD4+ T-cell proliferation plots in day 28 samples. Median CellTrace violet 
fluorescence in unstimulated samples was used to set the starting undivided population 
(vertical black line). Splenocytes were stimulated to proliferate using anti-CD3ε and anti-
CD28 antibody. *p < 0.05 vs. stimulated control. For statistical analysis a repeated-








DISCUSSION AND CONCLUSIONS 
This was one of the first studies to examine the effects of exercise on the time-
course of MDSC accumulation and function in a murine model of metastatic breast 
cancer. The hypothesis in response to our first specific aim was partially supported, as the 
numbers of MDSCs in WR+TUM were significantly lower in the spleen and blood when 
compared to SED+TUM. However, while MDSCs in the tumor of WR+TUM were 
trending lower compared to SED+TUM, this difference was not significant (p = 0.08). 
The second hypothesis of this study stated that MDSCs from exercising mice would have 
a reduced suppressive capacity. This hypothesis was also supported, evidenced by 
reduced suppression of T-cells in MDSC co-cultures from WR+TUM. Although there 
was a trend toward lower metastatic lung nodules in WR+TUM at day 24 and 28, this 
difference was not significant, which resulted in rejection of our third hypothesis. 
A growing body of literature suggests that physical activity, both acute and 
chronic, can favorably modulate immune function, with beneficial effects that potentially 
extend into the prevention and treatment of cancer. Physical activity and exercise is 
known to modulate inflammatory signaling, as well as the expansion and recruitment of 
both myeloid and lymphoid lineage immune cells (Hojman, 2017). Nearly all leukocyte 
populations are mobilized to the blood during acute exercise, and moderate intensity 




neutrophils (Pedersen & Hoffman-Goetz, 2017). MDSCs are immature myeloid cells 
routinely associated with a poorer prognosis in several cancer types (Veglia, Perego, & 
Gabrilovich, 2018) and pharmacological blockade of MDSCs can slow the growth of 
transplantable tumors (Davis et al., 2017; Kumar, Cheng et al., 2016). To date, only one 
study has investigated the effects of voluntary wheel running on the accumulation of 
MDSCs in a pre-clinical animal model and the present study aimed to determine if 
physical activity could improve antitumor immunity by reducing the accumulation of 
MDSCs in an orthotopic mouse model of breast cancer. Our data show that voluntary 
wheel running significantly delayed the accumulation of MDSCs in the spleen and blood. 
Additionally, there was a modest reduction in intratumoral MDSCs, however, these 
effects did not translate to smaller tumors by size and weight. Few groups have 
investigated the effects of physical activity on metastasis in 4T1 tumor-bearing mice and 
here we observed a non-significant 62% and 26% reduction in the number of metastatic 
lung nodules at days 24 and 28, respectively. In comparison, a recent study showed that 
wheel running in 4T1 tumor-bearing mice increased metastatic burden in the lungs when 
mice began running concurrently with tumor injection (Smeda et al., 2017). Turbitt et al. 
recently reported that energy restriction preventing weight gain in combination with 
voluntary wheel running significantly reduced M- and PMN-MDSCs in the spleen and 
tumor which led to a decrease in tumor growth (Turbitt et al., 2019). They also observed 
a non-significant decrease in metastatic burden in the lungs of wheel running mice fed ad 
libitum. By comparison, we report that physical activity can reduce the numbers of these 
cell populations independent of energy restriction. Taken together, these results suggest 




immunomodulatory effects of physical activity in tumor-bearing mice. One potential 
mechanism explaining these findings is the normalization of tumor vasculature with 
physical activity. For example, others have shown that 18 days of wheel running 
following implantation of 4T1 tumor cells resulted in improved vessel maturity, 
perfusion, and reduced hypoxia in the tumor microenvironment (Betof et al., 2015). 
Reductions in hypoxia have been shown to reduce the accumulation of MDSCs in 4T1 
tumors, decrease the expression of programmed cell death receptor ligand 1 (PD-L1), and 
increase the recruitment of T-cells to the tumor microenvironment (Qian et al., 2019). 
 A hallmark of MDSCs is the ability to suppress T-cell proliferation. MDSCs 
purified from SED+TUM mice appeared to preferentially suppress CD3+CD4+ T-cell 
proliferation while MDSCs from WR+TUM mice did not significantly suppress T-cell 
proliferation at 28 days, suggesting that physical activity may help normalize 
myelopoiesis and consequently the function of MDSCs. Compared to the findings of 
Turbitt et al. where they observed an increased proliferation of CD4+ T-cells harvested 
from physically active tumor-bearing mice (Turbitt et al., 2019), we showed that physical 
activity may directly alter the ability of MDSCs to suppress naïve T-cells evidenced by 
reduced T-cell suppression in MDSC co-cultures at day 28. Additionally, CD3+CD8+ T-
cell proliferation was significantly higher than controls in WR+TUM MDSC co-cultures 
at day 24 suggesting that these cells were promoting cytotoxic T-cell proliferation. 
MDSCs are often described as immature immune cells that are highly plastic depending 
on the context of the microenvironment. It is possible that the anti-inflammatory effects 
of physical activity may help normalize the aberrant myelopoiesis associated with 




Exercise had no effect on the rate of tumor progression in our study. Mixed 
results have been reported in the literature, with some studies in 4T1 tumor bearing mice 
showing that voluntary wheel running can slow the growth of 4T1 tumors (Betof et al., 
2015; Goh et al., 2014; Hagar et al., 2019), while other recent reports show that wheel 
running alone had no effect on tumor growth in 4T1 tumor-bearing mice (Smeda et al., 
2017; Turbitt et al., 2019). We propose that pre-training is important for the observed 
antitumor effects of physical activity which may be related to the running habits of 
rodents. Mice run the highest volumes the first several weeks after being housed with a 
running wheel and progressively decrease their running volume during subsequent weeks 
(Turner et al., 2005). Adaptations that promote an anti-inflammatory environment and 
progression toward more low-moderate running intensity may be important for the 
anticancer effects observed in pre-training models. In comparison, animals that begin 
running on the day of tumor inoculation may run at a volume and intensity that is 
ultimately immunosuppressive, negating any potential anticancer effects.  
Immune checkpoints regulate the immune system by promoting self-tolerance and 
preventing autoimmunity. Tumors are known to co-opt these immune checkpoint 
pathways to evade immune surveillance by T-cells specific for tumor antigens. 
Checkpoint inhibitor immunotherapy targets these immune checkpoints by blocking the 
interaction between checkpoint proteins that inactivate tumor-specific T-cells (Pardoll, 
2012). High levels of circulating MDSCs have been used as a predictor of the clinical 
response to immunotherapy with higher MDSCs being associated with treatment failure 
(De Henau et al., 2016; Ostrand-Rosenberg & Fenselau, 2018). In patients treated with 




with increased survival and improved treatment outcomes (Schilling et al., 2016). 
Additionally, depletion of MDSCs in pre-clinical mouse models significantly improves 
the outcomes of immunotherapy (Iida et al., 2017) and exercise has been shown to 
regulate inflammatory signals such as IL-6 and IL-1β that are implicated in MDSC 
accumulation (Bunt et al., 2007; Murphy et al., 2011; Pedersen & Hoffman-Goetz, 2017). 
Also, human breast cancer survivors who participated in a six month endurance training 
intervention had significant reductions in serum levels of systemic inflammatory 
cytokines such as TNF-α and IL-6 (Christensen et al., 2019). Further, an acute bout of 
exercise has been shown to increase serum concentrations of the anti-inflammatory 
cytokines interleukin 10 (IL-10) and interleukin-1 receptor antagonist (IL-1ra) (Petersen 
& Pedersen, 2004). Taken together, the anti-inflammatory effects of exercise described 
above in both animal models and human subjects have the potential to regulate several of 
the mechanisms involved in the accumulation and maintenance of MDSCs, specifically 
the IL-1β and IL-6 signaling pathways.  However, future work is necessary to determine 
whether these factors are underlying mechanisms behind the beneficial effects of physical 
activity observed in this study.  
Conclusions 
The present study investigated the effects of voluntary wheel running on the 
temporal accumulation of pro-tumor MDSCs and metastatic burden in a murine model of 
breast cancer. Despite a profound uptick in MDSC production in tumor-bearing animals, 
voluntary wheel running was able to delay the accumulation of immunosuppressive 
MDSCs. Furthermore, MDSCs harvested from physically active mice were less 




proliferation at day 24 post-tumor injection. Thus, findings from the present study 
suggest that physical activity may be a cost-effective way to reduce the severity of 
aberrant myelopoiesis that results in the accumulation of pathologically activated 
MDSCs, which could potentially improve the efficacy of now common immunotherapies 
such as programmed cell death 1 receptor (PD-1)/PD-L1 checkpoint inhibitors. 
Limitations 
 While the 4T1 tumor model has been used extensively to study MDSC biology, 
there are some limitations to our design.  It is possible that with a higher ratio of MDSCs, 
some suppressive effects may be observed at earlier timepoints. However, due to low 
numbers of MDSCs at the early timepoints, only a 2:1 splenocyte-to-suppressor ratio was 
used. Additionally, different subpopulations of MDSCs exert their immune suppressive 
effects using different mechanisms. Again, due to low cell numbers at early timepoints, 
especially in the M-MDSC population, both populations were pooled together in this 
study making it difficult to determine where the observed effects of physical activity are 
occurring. These findings were limited to the 4T1 breast cancer tumor model and future 
research into the effects of physical activity on MDSC accumulation in additional tumor 
models will help to confirm the results presented here. Experiments using S100A9 
knockout mice, which have a reduced capacity to generate MDSCs, would help confirm 
that the observed effects in this study were physical activity-dependent. Additional assays 
further characterizing the phenotype and function of T-cells are necessary to determine 
the effects of physical activity on antitumor immunity. Finally, mice were individually 
housed to accurately measure running activity. This may potentially affect immune 




rate to maintain core temperature when housed individually (Krohn, Sørensen, Ottesen, & 
Hansen, 2006). All animals in the present study were housed individually to account for 
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Confirming 4T1 Tumors Stimulate  
MDSC Production 
 
 Early experiments were conducted to confirm that the 4T1 model stimulates 
aberrant myelopoiesis and production of MDSCs in our hands. To confirm this, animals 
were assigned to one of four groups (n = 3-10/group); sedentary control (SED), wheel run 
control (WR), sedentary tumor (SED+TUM), or wheel run tumor (WR+TUM). Both WR 
groups ran for 6 weeks and SED groups were restricted to normal cage activity. After the 
6-week pre-training period, both TUM groups were inoculated with 1x104 4T1 cells and 
tumors were allowed to grow for 28 days. After 28 days, animals were sacrificed and 
MDSCs were analyzed in the spleen and blood. As expected, there was a significant 
increase in these cells in the spleen and blood of tumor-bearing animals when compared 
to non-tumor controls (Figure 12). Additionally, no differences were observed between 
SED and WR controls indicating that physical activity does not alter myelopoiesis in 
non-tumor animals, which is why this study excluded non-tumor control animals. 
 
Figure 12. 4T1-dependent MDSC production. MDSCs were analyzed in the spleen and 







Determining Earliest Timepoint for MDSC  
Functional Analysis 
 
 To determine the earliest timepoint to begin purification and functional analysis 
of MDSCs, pilot experiments were performed to determine when an uptick in MDSCs is 
observed in tumor-bearing animals. Animals were assigned to either a sedentary tumor 
(SED+TUM) or wheel run tumor (WR+TUM) group. After 6 weeks of wheel running, all 
animals were inoculated with 4T1 tumor cells and sacrificed 12 days later. While 
palpable tumors were present in these animals, MDSCs were relatively undetectable. 
MDSCs in the spleen (Figure 13A), blood (Figure 13B), and tumor (Figure 13C) were 
less than 5% of the total cells, which is similar to what is observed in non-tumor control 
animals (Figure 12). It is likely that these are normal myeloid cells that have not yet been 
pathologically activated, thus a later timepoint of 16 days was chosen as the earliest 





Figure 13. Early MDSCs. MDSCs in the (A) spleen, (B) blood, and (C) tumor of tumor-












Gating Strategy for Identifying Myeloid-Derived  
Suppressor Cells 
 
The cell surface markers CD11b, Ly6C, and Ly6G are the most common markers 
used to identify MDSCs in mice. PMN-MDSC are CD11b+Ly6CloLy6G+ and M-MDSC 
are CD11b+Ly6ChiLy6G-. As described in the methodology, samples were stained with 
fluorescent monoclonal antibodies for these markers and run on an Attune NxT flow 
cytometer. Data from the flow cytometer were exported and analyzed using FCS express 
(De Novo software). The gating strategy to identify and quantify these cells in a 
homogenous tissue sample is presented in Figure 14 below. Initial gating is used to 
identify cells and exclude debris with a low forward scatter (FSC-A) and low side scatter 
(SSC-A). Next, to exclude doublets, or cells that pass through the flow cytometer stuck 
together, the singlets gate was included. Single cells appear at a 45-degree angle on a 
FSC-A by forward scatter height (FSC-H) plot. After excluding doublets, primary gates 
around CD11b positive cells were established and then secondary gates were established 
around Ly6C positive or Ly6G positive cells. As described previously, both populations 
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